Bioactive constituents from Iris domestica attenuate OGD/R-induced PC12 cell injury by suppressing oxidative stress and mitochondrial apoptosis
Context Ischemic stroke (IS) causes neuronal injury involving oxidative stress, mitochondrial dysfunction, and apoptosis. Iris domestica (L.) Goldblatt & Mabb (Iridaceae), known as Shegan in traditional Chinese medicine, has potential neuroprotective properties; however, its structurally defined active constituents remain insufficiently characterized.Objective This study aimed to isolate secondary metabolites from I. domestica and evaluate their protective effects and potential mechanisms in an OGD/R-induced PC12 cell model.Materials and methods Secondary metabolites were isolated from I. domestica by chromatographic techniques and identified by 1D/2D NMR, high-resolution electrospray ionization mass spectrometry (HR-ESI-MS), and optical rotation. Neuroprotective activity was evaluated in oxygen-glucose deprivation/reoxygenation (OGD/R)-injured PC12 cells. Intracellular reactive oxygen species (ROS), mitochondrial membrane potential, and apoptosis-related proteins were further assessed, and network pharmacology and molecular docking were performed.Results Four previously undescribed compounds, irisdomeones A–C (1–3) and irisdomeoside F (4), with 21 known compounds (5–25), were isolated. Eleven compounds showed protective effects at 10 μM. Irisdomeone A (1) and belamchinoside D (24) exhibited the strongest activity and were further evaluated at 5 and 10 μM. Both reduced intracellular ROS accumulation, restored mitochondrial membrane potential, increased the Bcl-2/Bax ratio, and decreased cleaved caspase-3 expression. Network pharmacology and molecular docking suggested involvement of HIF-1 signaling and mitochondrial apoptosis-related targets.Conclusions Irisdomeone A and belamchinoside D exhibited protective effects against OGD/R-induced PC12 cell injury, associated with reduced oxidative stress, attenuation of mitochondrial dysfunction, and inhibition of apoptosis. These findings identify compounds 1 and 24 as promising cytoprotective constituents in this in vitro model.
Authors
- Tieqiang Zong (ORCID: https://orcid.org/0000-0002-6190-0286)
- Mei Jin (ORCID: https://orcid.org/0000-0002-6992-9243)
- Lantian Cui
- Shengbao Diao
- Zhengyu Hu
- Yanan Liu (ORCID: https://orcid.org/0009-0006-0874-5420)
- Long Jin
- Gao Li
- Wei Zhou
- Jinfeng Sun
Institutions
- Yanbian University (CN)
- Yanbian University Hospital (CN)
Publication Details
- Journal
- Pharmaceutical Biology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1080/13880209.2026.2764402
- Primary Topic
- Phytochemistry and Biological Activities
- Type
- article
- Field-Weighted Citation Impact
- 0.00